Maria Ellis
About Maria Ellis
Maria Ellis serves as the Executive Director at Nektar Therapeutics, bringing extensive experience in risk management and drug safety from her previous roles at various pharmaceutical companies. She possesses a comprehensive understanding of US and EU pharmaceutical regulations, which enhances her effectiveness in regulatory submissions.
Current Role at Nektar Therapeutics
Maria Ellis serves as the Executive Director at Nektar Therapeutics, a position she has held since 2023. In this role, she utilizes her extensive expertise in risk management and regulatory submissions to guide the company's initiatives. Her deep understanding of both US and EU pharmaceutical regulations supports Nektar's compliance and strategic objectives. Based in South San Francisco, California, she leads efforts to enhance drug safety and efficacy across various therapeutic areas.
Previous Experience at Gilead Sciences
Prior to her current role, Maria Ellis worked at Gilead Sciences as the Director of Risk Management from 2014 to 2016. During her tenure in the San Francisco Bay Area, she focused on identifying and mitigating risks associated with pharmaceutical products. Her experience at Gilead contributed to her comprehensive knowledge of risk management practices within the pharmaceutical industry.
Education and Expertise
Maria Ellis holds a Doctor of Pharmacy (PharmD) from Shenandoah University, where she studied from 2003 to 2005. Additionally, she earned a Bachelor of Science in Pharmacy from Temple University School of Pharmacy between 1993 and 1996. Her educational background provides a solid foundation for her extensive experience in drug safety science and regulatory affairs, particularly in managing projects across multiple therapeutic areas.
Career Background in Pharmaceutical Industry
Maria Ellis has a diverse career in the pharmaceutical industry, with roles spanning over two decades. She has held various positions, including Senior Product Manager at AstraZeneca and Director of Safety Surveillance and Risk Management at Pharmacyclics, an AbbVie Company. Her experience encompasses managing drug safety science projects in oncology, infectious diseases, and other therapeutic areas, demonstrating her versatility and depth of knowledge in the field.
Skills in Project Management and Communication
Maria Ellis is recognized for her strong project management skills, which enable her to manage competing priorities and meet project deadlines effectively. She possesses strong oral and written communication skills, essential for leadership and collaboration within the pharmaceutical sector. These skills have been pivotal in her roles, facilitating successful teamwork and project execution.